NCT06141408 PrEP Intervention in Prince George's County, Maryland
| NCT ID | NCT06141408 |
| Status | Recruiting |
| Phase | — |
| Sponsor | George Mason University |
| Condition | Hiv |
| Study Type | INTERVENTIONAL |
| Enrollment | 120 participants |
| Start Date | 2022-03-31 |
| Primary Completion | 2026-06-30 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 120 participants in total. It began in 2022-03-31 with a primary completion date of 2026-06-30.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The goal of the proposed research is to design a peer-based community intervention focused on addressing HIV stigma, and peer support to increase PrEP initiation in Prince George's County, MD. Participants will attend intervention events focused on stigma reduction and building community. Researchers will compare intervention and control group participants to see if there in a difference in PrEP initiation and adherence.
Eligibility Criteria
Inclusion Criteria: * Male * Black * HIV-negative * 18 years of age or older * Either residing in Prince George's County Maryland, or having a sexual partner in Prince George's County Maryland within the past year. Exclusion Criteria * HIV Positive * Refusal of HIV testing
Contact & Investigator
Rodman Turpin, PhD
PRINCIPAL INVESTIGATOR
George Mason University
Frequently Asked Questions
Who can join the NCT06141408 clinical trial?
This trial is open to male participants only, aged 18 Years or older, studying Hiv. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06141408 currently recruiting?
Yes, NCT06141408 is actively recruiting participants. Contact the research team at rturpin@gmu.edu for enrollment information.
Where is the NCT06141408 trial being conducted?
This trial is being conducted at Fairfax, United States.
Who is sponsoring the NCT06141408 clinical trial?
NCT06141408 is sponsored by George Mason University. The principal investigator is Rodman Turpin, PhD at George Mason University. The trial plans to enroll 120 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.